[1]
Wang, M.; Thanou, M. Targeting nanoparticles to cancer. Pharmacol. Res., 2010, 62, 90-99.
[2]
Son, D.; Lee, J.; Qiao, S.; Ghaffari, R.; Kim, J.; Lee, J.E.; Song, C.; Kim, S.J.; Lee, D.J.; Jun, S.W. Multifunctional wearable devices for diagnosis and therapy of movement disorders. Nat. Nanotechnol., 2014, 9, 397-404.
[3]
Cha, C.; Shin, S.R.; Annabi, N.; Dokmeci, M.R.; Khademhosseini, A. Carbon-based nanomaterials: Multifunctional materials for biomedical engineering. ACS Nano, 2013, 7, 2891-2897.
[4]
Wang, M.; Thanou, M. Targeting nanoparticles to cancer. Pharmacol. Res., 2010, 62, 90-99.
[5]
Spain, E.; Gilgunn, S.; Sharma, S.; Adamson, K.; Carthy, E.; O’Kennedy, R.; Forster, R.J. Detection of prostate specific antigen based on electrocatalytic platinum nanoparticles conjugated to a recombinant scFv antibody. Biosens. Bioelectron., 2016, 77, 759-766.
[6]
Pathak, Y.; Thassu, D. Drug delivery nanoparticles formulation and characterization; 1st Ed.; CRC Press: Taylor & Francis Group. , 2016.
[7]
Cheng, D.; Yong, X.; Zhu, T.; Qiu, Y.; Wang, J.; Zhu, H.; Ma, B.; Xie, J. Synthesis of protein nanoparticles for drug delivery. Eur. J. Med. Res., 2016, 2, 8-11.
[8]
Rostami, E.; Kashanian, S.; Azandaryani, A.H.; Faramarzi, H.; Dolatabadi, J.E.N.; Omidfar, K. Drug targeting using solid lipid nanoparticles. Chem. Phys. Lipids, 2014, 181, 56-61.
[9]
Allen, T.M.; Cullis, P.R. Drug delivery systems: Entering the mainstream. Science, 2004, 303, 1818-1822.
[10]
Ruskowitz, E.R.; DeForest, C.A. Photoresponsive biomaterials for targeted drug delivery and 4D cell culture. Nat. Rev. Mater., 2018, 3, 17087.
[11]
Amreddy, N.; Babu, A.; Muralidharan, R.; Panneerselvam, J.; Srivastava, A.; Ahmed, R.; Mehta, M.; Munshi, A.; Ramesh, R. Chapter five - recent advances in nanoparticle-based cancer drug and gene delivery. Adv. Cancer Res., 2018, 137, 115-170.
[12]
Chen, M-C.; Mi, F-L.; Liao, Z-X.; Hsiao, C-W.; Sonaje, K.; Chung, M-F.; Hsu, L-W.; Sung, H-W. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv. Drug Deliv. Rev., 2013, 65, 865-879.
[13]
Caruthers, S.D.; Wickline, S.A.; Lanza, G.M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol., 2007, 18, 26-30.
[14]
Xu, L.; Feng, L.; Dong, S.; Hao, J.; Yu, Q. Carbon nanotubes modified by a paramagnetic cationic surfactant for migration of DNA and proteins. Colloid. Surface. A., 2018, 559, 201-208.
[15]
Derakhshandeh, K.; Azandaryani, A.H. Active-targeted
Nanotherapy as Smart Cancer Treatment. Smart Drug Delivery
System., Ali Demir Sezer, Ed.; InTech Open: London. 2016, pp. 91-
116.
[16]
Li, H.; Wei, R.; Yan, G-H.; Sun, J.; Li, C.; Wang, H.; Shi, L.; Capobianco, J.A.; Sun, L. Smart self-assembled nanosystem based on water-soluble pillararene and rare-earth-doped upconversion nanoparticles for pH-responsive drug delivery. ACS Appl. Mater. Interfaces, 2018, 10, 4910-4920.
[17]
Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc., 2012, 134, 5722-5725.
[18]
Han, H.S.; Thambi, T.; Choi, K.Y.; Son, S.; Ko, H.; Lee, M.C.; Jo, D-G.; Chae, Y.S.; Kang, Y.M.; Lee, J.Y. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery. Biomacromolecules, 2015, 16, 447-456.
[19]
Zhang, T.; Zhou, S.; Hu, L.; Peng, B.; Liu, Y.; Luo, X.; Liu, X.; Song, Y.; Deng, Y. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. Drug Deliv. Transl. Res., 2018, 8, 602-616.
[20]
Rejeeth, C.; Pang, X.; Zhang, R.; Xu, W.; Sun, X.; Liu, B.; Lou, J.; Wan, J.; Gu, H.; Yan, W. Extraction, detection, and profiling of serum biomarkers using designed Fe 3 O4@ SiO2@ HA core-shell particles. Nano Res., 2018, 11, 68-79.
[21]
Mittal, R.; Patel, A.P.; Jhaveri, V.M.; Kay, S-I.S.; Debs, L.H.; Parrish, J.M.; Pan, D.R.; Nguyen, D.; Mittal, J.; Jayant, R.D. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opin. Drug Deliv., 2018, 15, 301-318.
[22]
Lavrador, P.; Gaspar, V.M.; Mano, J.F. Stimuli-responsive nanocarriers for delivery of bone therapeutics - Barriers and progresses. J. Control. Release, 2018, 273, 51-67.
[23]
Raghav, R.; Srivastava, S. Immobilization strategy for enhancing sensitivity of immunosensors: L-Asparagine-AuNPs as a promising alternative of EDC-NHS activated citrate-AuNPs for antibody immobilization. Biosens. Bioelectron., 2016, 78, 396-403.
[24]
Conde, J.; Dias, J.T.; Grazú, V.; Moros, M.; Baptista, P.V.; de la Fuente, J.M. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem., 2014, 2, 48.
[25]
Cheng, R.; Meng, F.; Deng, C.; Klok, H-A.; Zhong, Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials, 2013, 34, 3647-3657.
[26]
Chen, F.; Hong, H.; Zhang, Y.; Valdovinos, H.F.; Shi, S.; Kwon, G.S.; Theuer, C.P.; Barnhart, T.E.; Cai, W. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano, 2013, 7, 9027-9039.
[27]
Gao, Z.; Zhang, L.; Sun, Y. Nanotechnology applied to overcome tumor drug resistance. J. Control. Release, 2012, 162, 45-55.
[28]
Nikandish, N.; Hosseinzadeh, L.; Azandaryani, A.H.; Derakhshandeh, K. The role of nanoparticle in brain permeability: An in-vitro BBB model. Iran. J. Pharm. Res., 2016, 15, 403-413.
[29]
Piazza, R.D.; Brandt, J.V.; Gobo, G.G.; Tedesco, A.C.; Primo, F.L.; Marques, R.F.C.; Junior, M.J. mPEG-co-PCL nanoparticles: The influence of hydrophobic segment on methotrexate drug delivery. Colloid. Surf. A, 2018, 555, 142-149.
[30]
Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 2001, 70, 1-20.
[31]
Cho, K.; Wang, X.; Nie, S.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res., 2008, 14, 1310-1316.
[32]
Kumari, A.; Yadav, S.K.; Yadav, S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid. Surf. B., 2010, 75, 1-18.
[33]
Sharma, A.; Sharma, U.S. Liposomes in drug delivery: Progress and limitations. Int. J. Pharm., 1997, 154, 123-140.
[34]
Joshi, M.; Patravale, V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm., 2008, 346, 124-132.
[35]
Rostami, E.; Kashanian, S.; Azandaryani, A. Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization. Mol. Biol. Rep., 2014, 41, 3521-3527.
[36]
Kashanian, S. hemati Azandaryani, A.; Derakhshandeh, K. New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell. Int. J. Pharm., 2011, 6, 2393-2401.
[37]
Sperling, R.A.; Parak, W. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos. Trans. Royal Soc. A., 2010, 368, 1333-1383.
[38]
Feliu, N.; Docter, D.; Heine, M.; del Pino, P.; Ashraf, S.; Kolosnjaj-Tabi, J.; Macchiarini, P.; Nielsen, P.; Alloyeau, D.; Gazeau, F. In vivo degeneration and the fate of inorganic nanoparticles. Chem. Soc. Rev., 2016, 45, 2440-2457.
[39]
Hałupka-Bryl, M.; Bednarowicz, M.; Dobosz, B.; Krzyminiewski, R.; Zalewski, T.; Wereszczyńska, B.; Nowaczyk, G.; Jarek, M.; Nagasaki, Y. Doxorubicin loaded PEG-b-poly (4-vinylbenzylphosphonate) coated magnetic iron oxide nanoparticles for targeted drug delivery. J. Magn. Magn. Mater., 2015, 384, 320-327.
[40]
Wang, L.; Neoh, K.G.; Kang, E-T.; Shuter, B. Multifunctional polyglycerol-grafted Fe3O4@ SiO2 nanoparticles for targeting ovarian cancer cells. Biomaterials, 2011, 32, 2166-2173.
[41]
Gao, L.; Yu, J.; Liu, Y.; Zhou, J.; Sun, L.; Wang, J.; Zhu, J.; Peng, H.; Lu, W.; Yu, L. Tumor-penetrating peptide conjugated and doxorubicin loaded T1-T2 dual mode MRI contrast agents nanoparticles for tumor theranostics. Theranostics, 2018, 8, 92-108.
[42]
Li, Z.; Xu, W.; Wang, Y.; Shah, B.R.; Zhang, C.; Chen, Y.; Li, Y.; Li, B. Quantum dots loaded nanogels for low cytotoxicity, pH-sensitive fluorescence, cell imaging and drug delivery. Carbohydr. Polym., 2015, 121, 477-485.
[43]
Zhu, J.; Zheng, L.; Wen, S.; Tang, Y.; Shen, M.; Zhang, G.; Shi, X. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials, 2014, 35, 7635-7646.
[44]
Mandracchia, D.; Rosato, A.; Trapani, A.; Chlapanidas, T.; Montagner, I.M.; Perteghella, S.; Di Franco, C.; Torre, M.L.; Trapani, G.; Tripodo, G. Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery. Nanomed Nanotech. Biol. Med., 2017, 13, 1245-1254.
[45]
Yan, C.; Chen, C.; Hou, L.; Zhang, H.; Che, Y.; Qi, Y.; Zhang, X.; Cheng, J.; Zhang, Z. Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging. J. Drug Target., 2017, 25, 163-171.
[46]
Masoudipour, E.; Kashanian, S.; Maleki, N. A targeted drug delivery system based on dopamine functionalized nano graphene oxide. Chem. Phys. Lett., 2017, 668, 56-63.
[47]
Azandaryani, A.H.; Kashanian, S.; Shahlaei, M.; Derakhshandeh, K.; Motiei, M.; Moradi, S. A comprehensive physicochemical, in vitro and molecular characterization of letrozole incorporated chitosan-lipid nanocomplex. Pharm. Res., 2019, 36, 62.
[48]
Zhao, Q.; Wang, S.; Yang, Y.; Li, X.; Di, D.; Zhang, C.; Jiang, T.; Wang, S. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging. Mater. Sci. Eng. C, 2017, 78, 475-484.
[49]
Tsai, C.S. Biomacromolecules: Introduction to structure, function and informatics; John Wiley & Sons Inc.: Hoboken, New Jersey, 2007.
[50]
Arkan, E.; Azandaryani, A.; Moradipour, P.; Behbood, L. Biomacromolecular based fibers in nanomedicine: A combination of drug delivery and tissue engineering. Curr. Pharm. Biotechnol., 2017, 18, 909-924.
[51]
Sharma, P.; Mittal, H.; Jindal, R.; Jindal, D.; Alhassan, S.M. Sustained delivery of atenolol drug using gum dammar crosslinked polyacrylamide and zirconium based biodegradable hydrogel composites. Colloid. Surf. A, 2019, 562, 136-145.
[52]
Wang, Z.; Qian, L.; Wang, X.; Zhu, H.; Yang, F.; Yang, X. Hollow DNA/PLL microcapsules with tunable degradation property as efficient dual drug delivery vehicles by α-chymotrypsin degradation. Colloid. Surf. A, 2009, 332, 164-171.
[53]
Scofield, M. Nucleic Acids: xPharm: The Comprehensive Pharmacology Reference. Enna, S.J; Bylund, D.B., Ed.; Elsevier Inc.: Amsterdam, 2007, pp. 1-15.
[54]
Zhou, J.; Liu, J.; Cheng, C.J.; Patel, T.R.; Weller, C.E.; Piepmeier, J.M.; Jiang, Z.; Saltzman, W.M. Biodegradable poly (amine-co-ester) terpolymers for targeted gene delivery. Nat. Mater., 2012, 11, 82-90.
[55]
Hardee, C.L.; Arévalo-Soliz, L.M.; Hornstein, B.D.; Zechiedrich, L. Advances in non-viral DNA vectors for gene therapy. Genes., 2017, 8, 1-22.
[56]
Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. The shape and structure of proteins, 4th ed; Garland Science: New York, 2002.
[57]
Bäumer, N.; Appel, N.; Terheyden, L.; Buchholz, F.; Rossig, C.; Müller-Tidow, C.; Berdel, W.E.; Bäumer, S. Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown. Nat. Protoc., 2016, 11, 22-36.
[58]
Yun, Y.; Cho, Y.W.; Park, K. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv. Drug Deliv. Rev., 2013, 65, 822-832.
[59]
Medintz, I.L.; Delehanty, J.B.; Breger, J.; Muttenthaler, M.; Dawson, P.E. Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos. U.S. Patent 10,183,080, January 22. 2019.
[60]
Ulbrich, K.; Hekmatara, T.; Herbert, E.; Kreuter, J. Transferrin-and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the Blood-Brain Barrier (BBB). Eur. J. Pharm. Biopharm., 2009, 71, 251-256.
[61]
Couvreur, P. Nanoparticles in drug delivery: Past, present and future. Adv. Drug Deliv. Rev., 2013, 65, 21-23.
[62]
Montenegro, J-M.; Grazu, V.; Sukhanova, A.; Agarwal, S.; Jesus, M.; Nabiev, I.; Greiner, A.; Parak, W.J. Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery. Adv. Drug Deliv. Rev., 2013, 65, 677-688.
[63]
She, W.; Luo, K.; Zhang, C.; Wang, G.; Geng, Y.; Li, L.; He, B.; Gu, Z. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy. Biomaterials, 2013, 34, 1613-1623.
[64]
Kularatne, R.N.; Washington, K.E.; Bulumulla, C.; Calubaquib, E.L.; Biewer, M.C.; Oupicky, D.; Stefan, M.C. Histone deacetylase inhibitor (HDACi) conjugated polycaprolactone for combination cancer therapy. Biomacromolecules, 2018, 19, 1082-1089.
[65]
Lee, S.; Lee, Y.; Kim, H.; Lee, D.Y.; Jon, S. Bilirubin nanoparticle-assisted delivery of a small molecule-drug conjugate for targeted cancer therapy. Biomacromolecules, 2018, 19, 2270-2277.
[66]
Bartczak, D.; Kanaras, A.G. Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. Langmuir, 2011, 27, 10119-10123.
[67]
Joshy, K.; Susan, M.A.; Snigdha, S.; Nandakumar, K.; Laly, A.P.; Sabu, T. Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery. Int. J. Biol. Macromol., 2018, 107, 929-937.
[68]
Kamra, T.; Chaudhary, S.; Xu, C.; Montelius, L.; Schnadt, J.; Ye, L. Covalent immobilization of molecularly imprinted polymer nanoparticles on a gold surface using carbodiimide coupling for chemical sensing. J. Colloid Interface Sci., 2016, 461, 1-8.
[69]
Pham, Y.; Nguyen, A.T.; Phan, T.N.; Chu, L.L.; Nguyen, D.Q.; Nguyen, H.M.; Nam, N.H.; Luong, N.H. Specificity and processing rate enhancement of Mycobacterium tuberculosis diagnostic procedure using antibody-coupled magnetic nanoparticles. Int. J. Nanotechnol., 2015, 12, 335-346.
[70]
Motiei, M.; Kashanian, S.; Taherpour, A. Hydrophobic amino acids grafted onto chitosan: A novel amphiphilic chitosan nanocarrier for hydrophobic drugs. Drug Dev. Ind. Pharm., 2017, 43, 1-11.
[71]
Manoochehri, S.; Darvishi, B.; Kamalinia, G.; Amini, M.; Fallah, M.; Ostad, S.N.; Atyabi, F.; Dinarvand, R. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU J. Pharm. Sci, 2013, 21, 1.
[72]
Hanafy, N.A.; Quarta, A.; Di Corato, R.; Dini, L.; Nobile, C.; Tasco, V.; Carallo, S.; Cascione, M.; Malfettone, A.; Soukupova, J. Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells. J. Mater. Sci. Mater. Med., 2017, 28, 1-11.
[73]
Mallick, A.; More, P.; Ghosh, S.; Chippalkatti, R.; Chopade, B.A.; Lahiri, M.; Basu, S. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells. ACS Appl. Mater. Interfaces, 2015, 7, 7584-7598.
[74]
Hettiarac, S.; Graham, R.; Mintz, K.J.; Zhou, Y.; Vanni, S.; Peng, Z.; Leblanc, R. Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors. Nanoscale, 2019, 28, 6192-6205.
[75]
Iijima, S. Helical microtubules of graphitic carbon. Nature, 1991, 354, 56-58.
[76]
Mehra, N.K.; Palakurthi, S. Interactions between carbon nanotubes and bioactives: A drug delivery perspective. Drug Discov. Today, 2016, 21, 585-597.
[77]
Gao, Y.; Kyratzis, I. Covalent immobilization of proteins on carbon nanotubes using the cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-a critical assessment. Bioconjug. Chem., 2008, 19, 1945-1950.
[78]
Kam, N.W.S.; O’Connell, M.; Wisdom, J.A.; Dai, H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. USA, 2005, 102, 11600-11605.
[79]
Mosleh, A.; Heintz, A.; Lim, K.T.; Kim, J.W.; Beitle, R. Permeability enhancement of Escherichia coli by single‐walled carbon nanotube treatment. Biotechnol. Prog., 2017, 33, 654-657.
[80]
Ou, Z.; Wu, B.; Xing, D.; Zhou, F.; Wang, H.; Tang, Y. Functional single-walled carbon nanotubes based on an integrin αvβ3 monoclonal antibody for highly efficient cancer cell targeting. Nanotechnology, 2009, 20, 105102.
[81]
Firer, M.A.; Gellerman, G. Targeted drug delivery for cancer therapy: The other side of antibodies. J. Hematol. Oncol., 2012, 5, 1-16.
[82]
Axup, J.Y.; Bajjuri, K.M.; Ritland, M.; Hutchins, B.M.; Kim, C.H.; Kazane, S.A.; Halder, R.; Forsyth, J.S.; Santidrian, A.F.; Stafin, K. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. P. Nat. Acad. Sci., 2012, 109, 16101-16106.
[83]
Bengtsson, K.L.; Song, H.; Stertman, L.; Liu, Y.; Flyer, D.C.; Massare, M.J.; Xu, R-H.; Zhou, B.; Lu, H.; Kwilas, S.A.; Hahn, T.J.; Kpamegan, E.; Hooper, J.; Carrion, Jr, R.; Glenn, G.; Smith, G. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine, 2016, 34, 1927-1935.
[84]
Pende, D.; Cantoni, C.; Rivera, P.; Vitale, M.; Castriconi, R.; Marcenaro, S.; Nanni, M.; Biassoni, R.; Bottino, C.; Moretta, A. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol., 2001, 31, 1076-1086.
[85]
Kucinskaite-Kodze, I.; Pleckaityte, M.; Bremer, C.M.; Seiz, P.L.; Zilnyte, M.; Bulavaite, A.; Mickiene, G.; Zvirblis, G.; Sasnauskas, K.; Glebe, D. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen. Virus Res., 2016, 211, 209-221.
[86]
Feng, Y.; Forsell, M.N.; Flynn, B.; Adams, W.; Loré, K.; Seder, R.; Wyatt, R.T.; Hedestam, G.B.K. Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants. Virology, 2013, 446, 56-65.
[87]
Loureiro, J.A.; Gomes, B.; Fricker, G.; Coelho, M.A.N.; Rocha, S.; Pereira, M.C. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment. Colloid. Surf. B., 2016, 145, 8-13.
[88]
De Cesare, M.; Sfondrini, L.; Pennati, M.; De Marco, C.; Motta, V.; Tagliabue, E.; Deraco, M.; Balsari, A.; Zaffaroni, N. CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts. J. Transl. Med., 2016, 14, 1.
[89]
Milley, B.; Kiwan, R.; Ott, G.S.; Calacsan, C.; Kachura, M.; Campbell, J.D.; Kanzler, H.; Coffman, R.L. Optimization, production, and characterization of a CpG-Oligonucleotide-Ficoll conjugate nanoparticle adjuvant for enhanced immunogenicity of anthrax protective antigen. Bioconjug. Chem., 2016, 27, 1293-1304.
[90]
Sunoqrot, S.; Bae, J.W.; Pearson, R.M.; Shyu, K.; Liu, Y.; Kim, D-H.; Hong, S. Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles. Biomacromolecules, 2012, 13, 1223-1230.
[91]
Sunoqrot, S.; Bugno, J.; Lantvit, D.; Burdette, J.E.; Hong, S. Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles. J. Control. Release, 2014, 191, 115-122.
[92]
Hua, X.; Zhou, Z.; Yuan, L.; Liu, S. Selective collection and detection of MCF-7 breast cancer cells using aptamer-functionalized magnetic beads and quantum dots based nano-bio-probes. Anal. Chim. Acta, 2013, 788, 135-140.
[93]
Chen, M.; Ouyang, H.; Zhou, S.; Li, J.; Ye, Y. PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses. Cell. Immunol., 2014, 287, 91-99.
[94]
Kaluzova, M.; Bouras, A.; Machaidze, R.; Hadjipanayis, C.G. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget, 2015, 6, 8788.
[95]
Helm, F.; Fricker, G. Liposomal conjugates for drug delivery to the central nervous system. Pharmaceutics, 2015, 7, 27-42.
[96]
Alibolandi, M.; Mohammadi, M.; Taghdisi, S.M.; Ramezani, M.; Abnous, K. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr. Polym., 2017, 155, 218-229.
[97]
Alibolandi, M.; Taghdisi, S.M.; Ramezani, P.; Hosseini Shamili, F.; Farzad, S.A.; Abnous, K.; Ramezani, M. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int. J. Pharm., 2017, 519, 352-364.
[98]
Azandaryani, A.H.; Kashanian, S.; Derakhshandeh, K. Folate conjugated hybrid nanocarrier for targeted letrozole delivery in breast cancer treatment. Pharm. Res., 2017, 34, 2798-2808.
[99]
Martínez-Carmona, M.; Lozano, D.; Colilla, M.; Vallet-Regí, M. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Acta Biomater., 2018, 65, 393-404.
[100]
Hu, F.; Chen, K.; Xu, H.; Hongchen, G. Design and Preparation of Bi-functionalized Short-chain Modified Zwitterionic Nanoparticles. Acta Biomater., 2018, 72, 239-247.
[101]
Xu, S.; Cui, F.; Huang, D.; Zhang, D.; Zhu, A.; Sun, X.; Cao, Y.; Ding, S.; Wang, Y.; Gao, E. PD-l1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. Int. J. Nanomedicine, 2019, 14, 17.
[102]
Baumann, M.; Baxendale, I.R.; Ley, S.V.; Nikbin, N.; Smith, C.D. Azide monoliths as convenient flow reactors for efficient Curtiusrearrangement reactions. Org. Biomol. Chem., 2008, 6, 1587-159.
[103]
Glebe, U.; Santos de Miranda, B.; van Rijn, P.; Boker, A. Chapter 1
- Synthetic Modifications of Proteins. Bio-Synthetic Hybrid
Materials and Bionanoparticles: A Biological Chemical Approach
Towards Material Science., Alexander, B.; Patrick van, R.;Editors.;
The Royal Society of Chemistry: Cambridge, UK. 2015, pp. 1-29.
[104]
Somani, R.R.; Sabnis, A.A.; Vaidya, A.V. Click chemical reactions: An emerging approach and its pharmaceutical applications. Int. J. Pharm. Phytopharm. Res, 2017, 1, 322-331.
[105]
Spicer, C.D.; Davis, B.G. Selective chemical protein modification. Nat. Commun., 2014, 5, 4750.
[106]
Hein, C.D.; Liu, X-M.; Wang, D. Click chemistry, a powerful tool for pharmaceutical sciences. Pharm. Res., 2008, 25, 2216-2230.
[107]
Chen, Y.; Xianyu, Y.; Wu, J.; Yin, B.; Jiang, X. Click chemistry-mediated nanosensors for biochemical assays. Theranostics, 2016, 6, 969.
[108]
Sánchez-Tirado, E.; González-Cortés, A.; Yáñez-Sedeño, P.; Pingarrón, J.M. Carbon nanotubes functionalized by click chemistry as scaffolds for the preparation of electrochemical immunosensors. Application to the determination of TGF-beta 1 cytokine. Analyst., 2016, 141, 5730-5737.
[109]
Lallana, E.; Sousa-Herves, A.; Fernandez-Trillo, F.; Riguera, R.; Fernandez-Megia, E. Click chemistry for drug delivery nanosystems. Pharm. Res., 2012, 29, 1-34.
[110]
Liu, T.; Li, X.; Qian, Y.; Hu, X.; Liu, S. Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties. Biomaterials, 2012, 33, 2521-2531.
[111]
Saxon, E.; Bertozzi, C.R. Cell surface engineering by a modified Staudinger reaction. Science, 2000, 287, 2007-2010.
[112]
O’Reilly, R.K.; Joralemon, M.J.; Wooley, K.L.; Hawker, C.J. Functionalization of micelles and shell cross-linked nanoparticles using click chemistry. Chem. Mater., 2005, 17, 5976-5988.
[113]
Neves, A.A.; Stöckmann, H.; Wainman, Y.A.; Kuo, J.C.; Fawcett, S.; Leeper, F.J.; Brindle, K.M. Imaging cell surface glycosylation in vivo using “double click” chemistry. Bioconjug. Chem., 2013, 24, 934-941.
[114]
Kotagiri, N.; Li, Z.; Xu, X.; Mondal, S.; Nehorai, A.; Achilefu, S. Antibody quantum dot conjugates developed via copper-free click chemistry for rapid analysis of biological samples using a microfluidic microsphere array system. Bioconjug. Chem., 2014, 25, 1272-1281.
[115]
Lu, L.; Yuan, L.; Yan, J.; Tang, C.; Wang, Q. Development of core-shell nanostructures by in situ assembly of pyridine-grafted diblock copolymer and transferrin for drug delivery applications. Biomacromolecules, 2016, 11, 2321-2328.
[116]
Hong, Z-Y.; Lv, C.; Liu, A-A.; Liu, S-L.; Sun, E-Z.; Zhang, Z-L.; Lei, A-W.; Pang, D-W. Clicking hydrazine and aldehyde: The Way to Labeling of Viruses with Quantum dots. ACS Nano, 2015, 9, 11750-11760.
[117]
Schieber, C.; Bestetti, A.; Lim, J.P.; Ryan, A.D.; Nguyen, T.L.; Eldridge, R.; White, A.R.; Gleeson, P.A.; Donnelly, P.S.; Williams, S.J. Conjugation of transferrin to azide‐modified Cdse/ZnS core-shell quantum dots using cyclooctyne click chemistry. Angew. Chem. Int. Ed. Engl., 2012, 51, 10523-10527.
[118]
Hayat, A.; Sassolas, A.; Marty, J-L.; Radi, A-E. Highly sensitive ochratoxin A impedimetric aptasensor based on the immobilization of azido-aptamer onto electrografted binary film via click chemistry. Talanta, 2013, 103, 14-19.
[119]
Yao, G.; Pei, H.; Li, J.; Zhao, Y.; Zhu, D.; Zhang, Y.; Lin, Y.; Huang, Q.; Fan, C. Clicking DNA to gold nanoparticles: poly-adenine-mediated formation of monovalent DNA-gold nanoparticle conjugates with nearly quantitative yield. NPG Asia Mater., 2015, 7, e159.
[120]
Heuer-Jungemann, A.; Kirkwood, R.; El-Sagheer, A.H.; Brown, T.; Kanaras, A.G. Copper-free click chemistry as an emerging tool for the programmed ligation of DNA-functionalised gold nanoparticles. Nanoscale, 2013, 5, 7209-7212.
[121]
Brennan, J.L.; Hatzakis, N.S.; Tshikhudo, T.R.; Dirvianskyte, N.; Razumas, V.; Patkar, S.; Vind, J.; Svendsen, A.; Nolte, R.J.; Rowan, A.E. Bionanoconjugation via click chemistry: The creation of functional hybrids of lipases and gold nanoparticles. Bioconjug. Chem., 2006, 17, 1373-1375.
[122]
Zong, H.; Goonewardena, S.N.; Chang, H-N.; Otis, J.B.; Baker, Jr, J.R. Sequential and parallel dual labeling of nanoparticles using click chemistry. Bioorg. Med. Chem., 2014, 22, 6288-6296.
[123]
Qin, M.; Zong, H.; Kopelman, R. Click conjugation of peptide to hydrogel nanoparticles for tumor-targeted drug delivery. Biomacromolecules, 2014, 15, 3728-3734.
[124]
Zhou, Z.; Badkas, A.; Stevenson, M.; Lee, J-Y.; Leung, Y-K. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery. Int. J. Pharm., 2015, 487, 81-90.
[125]
Finetti, C.; Sola, L.; Pezzullo, M.; Prosperi, D.; Colombo, M.; Riva, B.; Avvakumova, S.; Morasso, C.; Picciolini, S.; Chiari, M. Click chemistry immobilization of antibodies on polymer coated gold nanoparticles. Langmuir, 2016, 32, 7435-7441.
[126]
Parsamanesh, M.; Dadkhah Tehrani, A. Synthesize of new fluorescent polymeric nanoparticle using modified cellulose nanowhisker through click reaction. Carbohydr. Polym., 2016, 136, 1323-1331.
[127]
van Lith, S.A.; van Duijnhoven, S.M.; Navis, A.C.; Leenders, W.P.; Dolk, E.; Wennink, J.W.; van Nostrum, C.F.; van Hest, J.C. Legomedicine a versatile chemo-enzymatic approach for the preparation of targeted dual-labeled llama antibody-nanoparticle conjugates. Bioconjug. Chem., 2017, 28, 539-548.
[128]
Kyriazi, M-E.; Giust, D.; El-Sagheer, A.H.; Lackie, P.M.; Muskens, O.L.; Brown, T.; Kanaras, A.G. Multiplexed mRNA sensing and combinatorial-targeted drug delivery using DNA-gold nanoparticle dimers. ACS Nano, 2018, 12, 3333-3340.
[129]
Hou, G.; Qian, J.; Xu, W.; Sun, T.; Wang, Y.; Wang, J.; Ji, L.; Suo, A. A novel pH-sensitive targeting polysaccharide-gold nanorod conjugate for combined photothermal-chemotherapy of breast cancer. Carbohydr. Polym., 2019, 212, 334-344.
[130]
Ding, Y.; Zhou, Y-Y.; Chen, H.; Geng, D-D.; Wu, D-Y.; Hong, J.; Shen, W-B.; Hang, T-J.; Zhang, C. The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials, 2013, 34, 10217-10227.
[131]
Ghosh, P.; Han, G.; De, M.; Kim, C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev., 2008, 60, 1307-1315.
[132]
Li, J-L.; Wang, L.; Liu, X-Y.; Zhang, Z-P.; Guo, H-C.; Liu, W-M.; Tang, S-H. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett., 2009, 274, 319-326.
[133]
Ahirwal, G.K.; Mitra, C.K. Direct electrochemistry of horseradish peroxidase-gold nanoparticles conjugate. Sensors., 2009, 9, 881-894.
[134]
Vigderman, L.; Zubarev, E.R. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv. Drug Deliv. Rev., 2013, 65, 663-676.
[135]
Sun, Y.; Liu, H.; Cheng, L.; Zhu, S.; Cai, C.; Yang, T.; Yang, L.; Ding, P. Thiol Michael addition reaction: a facile tool for introducing peptides into polymer‐based gene delivery systems. Polym. Int., 2018, 67, 25-31.
[136]
Kotamraju, V.R.; Sharma, S.; Kolhar, P.; Agemy, L.; Pavlovich, J.; Ruoslahti, E. Increasing tumor accessibility with conjugatable disulfide-bridged tumor-penetrating peptides for cancer diagnosis and treatment. Breast Cancer, 2015, 9, 79.
[137]
Ye, Y.; Zhu, L.; Ma, Y.; Niu, G.; Chen, X. Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging. Bioorg. Med. Chem. Lett., 2011, 21, 1146-1150.
[138]
Lee, J-S.; Lytton-Jean, A.K.; Hurst, S.J.; Mirkin, C.A. Silver nanoparticle-oligonucleotide conjugates based on DNA with triple cyclic disulfide moieties. Nano Lett., 2007, 7, 2112-2115.
[139]
Walter, J.G.; Petersen, S.; Stahl, F.; Scheper, T.; Barcikowski, S. Laser ablation-based one-step generation and bio-functionalization of gold nanoparticles conjugated with aptamers. J. Nanobiotechnology, 2010, 8, 1-11.
[140]
Chen, M.; Bi, S.; Jia, X.; He, P. Aptamer-conjugated bio-bar-code Au-Fe3O4 nanoparticles as amplification station for electroche-miluminescence detection of tumor cells. Anal. Chim. Acta, 2014, 837, 44-51.
[141]
Kalmodia, S.; Vandhana, S.; Rama, B.T.; Jayashree, B.; Seethalakshmi, T.S.; Umashankar, V.; Yang, W.; Barrow, C.J.; Krishnakumar, S.; Elchuri, S.V. Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: A novel approach to enhance the radical scavenging property in cancer cell. Cancer Nanotechnol., 2016, 7, 1-19.
[142]
Dasari, B.C.; Cashman, S.M.; Kumar-Singh, R. Reducible PEG-POD/DNA nanoparticles for gene transfer in vitro and in vivo; application in a mouse model of age related macular degeneration. Mol. Ther. Nucleic Acids, 2017, 8, 77-89.
[143]
Yan, J.; He, W.; Yan, S.; Niu, F.; Liu, T.; Ma, B.; Shao, Y.; Yan, Y.; Yang, G.; Lu, W. Self-assembled peptide–lanthanide nanoclusters for safe tumor therapy: Overcoming and utilizing biological barriers to peptide drug delivery. ACS Nano, 2018, 12, 2017-2026.
[144]
Zhang, B.; Shen, S.; Liao, Z.; Shi, W.; Wang, Y.; Zhao, J.; Hu, Y.; Yang, J.; Chen, J.; Mei, H. Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles. Biomaterials, 2014, 35, 4088-4098.
[145]
Rai, A.; Pinto, S.; Velho, T.R.; Ferreira, A.F.; Moita, C.; Trivedi, U.; Evangelista, M.; Comune, M.; Rumbaugh, K.P.; Simões, P.N.; Moita, L.; Ferreira, L. One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. Biomaterials, 2016, 85, 99-110.
[146]
Lee, D.; Heo, D.N.; Kim, H-J.; Ko, W-K.; Lee, S.J.; Heo, M.; Bang, J.B.; Lee, J.B.; Hwang, D-S.; Do, S.H. Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles. Sci. Rep. UK, 2016, 6, 27336.
[147]
Oroujeni, M.; Kaboudin, B.; Xia, W.; Jönsson, P.; Ossipov, D.A. Conjugation of cyclodextrin to magnetic Fe3O4 nanoparticles via polydopamine coating for drug delivery. Prog. Org. Coat., 2018, 114, 154-161.
[148]
Sun, H.; Li, S.; Qi, W.; Xing, R.; Zou, Q.; Yan, X. Stimuli-responsive nanoparticles based on co-assembly of naturally-occurring biomacromolecules for in vitro photodynamic therapy. Colloid. Surf. A., 2018, 538, 795-801.
[149]
Jain, A.; Cheng, K. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. J. Control. Release, 2017, 245, 27-40.
[150]
Chivers, C.E.; Koner, A.L.; Lowe, E.D.; Howarth, M. How the biotin-streptavidin interaction was made even stronger: Investigation via crystallography and a chimaeric tetramer. Biochem. J., 2011, 435, 55-63.
[151]
Zamolo, V.A.; Modugno, G.; Lubian, E.; Cazzolaro, A.; Mancin, F.; Giotta, L.; Mastrogiacomo, D.; Valli, L.; Saccani, A.; Krol, S. Selective targeting of proteins by hybrid polyoxometalates: Interaction between a bis-biotinylated hybrid conjugate and avidin. Front Chem., 2018, 6, Article 278.
[152]
Ren, W.X.; Han, J.; Uhm, S.; Jang, Y.J.; Kang, C.; Kim, J-H.; Kim, J.S. Recent development of biotin conjugation in biological imaging, sensing, and target delivery. Chem. Commun., 2015, 51, 10403-10418.
[153]
Wilchek, M.; Bayer, E.A.; Livnah, O. Essentials of biorecognition: the (strept) avidin-biotin system as a model for protein-protein and protein-ligand interaction. Immunol. Lett., 2006, 103, 27-32.
[154]
Bajpayee, A.G.; Quadir, M.A.; Hammond, P.T.; Grodzinsky, A.J. Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. Osteoarthritis Cartilage, 2016, 24, 71-81.
[155]
Lakshmipriya, T.; Gopinath, S.C.; Hashim, U.; Tang, T-H. Signal enhancement in ELISA: Biotin-streptavidin technology against gold nanoparticles. J. Taibah Univ. Med. Sci, 2016, 11, 432-438.
[156]
Lakshmipriya, T.; Gopinath, S.C.; Tang, T-H. Biotin-Streptavidin Competition Mediates Sensitive Detection of Biomolecules in Enzyme Linked Immunosorbent Assay. PLoS One, 2016, 11, 1-14.
[157]
Greenwood, C.; Ruff, D.; Kirvell, S.; Johnson, G.; Dhillon, H.S.; Bustin, S.A. Proximity assays for sensitive quantification of proteins. Biomol Detect. Quantif., 2015, 4, 10-16.
[158]
George, A.; Zhou, M.; Ye, R.; Patrick, M-A.; Anthony, T.; Frederick, S. Connecting DNA origami structures using the biotin-streptavidin specific binding. Afr. J. Biotechnol., 2015, 14, 2258-2264.
[159]
Leach, J.C.; Wang, A.; Ye, K.; Jin, S. A RNA-DNA hybrid aptamer for nanoparticle-based prostate tumor targeted drug delivery. Int. J. Mol. Sci., 2016, 17, 380.
[160]
Palanca-Wessels, M.C.; Booth, G.C.; Convertine, A.J.; Lundy, B.B.; Berguig, G.Y.; Press, M.F.; Stayton, P.S.; Press, O.W. Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells. Oncotarget, 2016, 7, 9561-9575.
[161]
van der Meer, S.B.; Knuschke, T.; Frede, A.; Schulze, N.; Westendorf, A.M.; Epple, M. Avidin-conjugated calcium phosphate nanoparticles as a modular targeting system for the attachment of biotinylated molecules in vitro and in vivo. Acta Biomater., 2017, 57, 414-425.
[162]
García-Astrain, C.; Avérous, L. Synthesis and evaluation of functional alginate hydrogels based on click chemistry for drug delivery applications. Carbohydr. Polym., 2018, 190, 271-280.
[163]
Jin, K.; Leitsch, E.K.; Chen, X.; Heath, W.H.; Torkelson, J.M. Segmented thermoplastic polymers synthesized by thiol-ene click chemistry: Examples of thiol-norbornene and thiol-maleimide click reactions. Macromolecules, 2018, 51, 3620-3631.
Download PDF Flyer